AR107737A1 - Método y sistema para la evaluación temprana de riesgo de resultado de parto prematuro - Google Patents

Método y sistema para la evaluación temprana de riesgo de resultado de parto prematuro

Info

Publication number
AR107737A1
AR107737A1 ARP170100387A ARP170100387A AR107737A1 AR 107737 A1 AR107737 A1 AR 107737A1 AR P170100387 A ARP170100387 A AR P170100387A AR P170100387 A ARP170100387 A AR P170100387A AR 107737 A1 AR107737 A1 AR 107737A1
Authority
AR
Argentina
Prior art keywords
microbiome
abundance
risk
taxonomic
microbial
Prior art date
Application number
ARP170100387A
Other languages
English (en)
Spanish (es)
Inventor
Mitali Merchant
Nishal Kumar Pinna
Anirban Dutta
Mohammed Monzoorul Haque
Sharmila Shekhar Mande
Original Assignee
Tata Consultancy Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tata Consultancy Services Ltd filed Critical Tata Consultancy Services Ltd
Publication of AR107737A1 publication Critical patent/AR107737A1/es

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/43Detecting, measuring or recording for evaluating the reproductive systems
    • A61B5/4306Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
    • A61B5/4343Pregnancy and labour monitoring, e.g. for labour onset detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Molecular Biology (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Bioethics (AREA)
  • Evolutionary Computation (AREA)
  • Artificial Intelligence (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Wood Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
ARP170100387A 2016-02-16 2017-02-16 Método y sistema para la evaluación temprana de riesgo de resultado de parto prematuro AR107737A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201621005426 2016-02-16

Publications (1)

Publication Number Publication Date
AR107737A1 true AR107737A1 (es) 2018-05-30

Family

ID=59624818

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170100387A AR107737A1 (es) 2016-02-16 2017-02-16 Método y sistema para la evaluación temprana de riesgo de resultado de parto prematuro

Country Status (7)

Country Link
US (1) US11062808B2 (OSRAM)
EP (1) EP3416653B1 (OSRAM)
JP (1) JP7060518B2 (OSRAM)
CN (1) CN108778287B (OSRAM)
AR (1) AR107737A1 (OSRAM)
AU (1) AU2017220785B2 (OSRAM)
WO (1) WO2017141169A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2699733C1 (ru) * 2018-03-30 2019-09-09 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московская государственная академия ветеринарной медицины и биотехнологии - МВА имени К.И. Скрябина" (ФГБОУ ВО МГАВМиБ - МВА имени К.И. Скрябина) Способ лабораторной ультразвуковой диагностики ранних стадий жеребости
EP3620539A1 (en) * 2018-08-10 2020-03-11 Tata Consultancy Services Limited Method and system for improving amplicon sequencing based taxonomic resolution of microbial communities
GB2612911B (en) * 2019-02-14 2023-11-22 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
CN112587089B (zh) * 2020-11-19 2023-04-21 新希望六和股份有限公司 基于人工智能的妊娠检测方法、装置、计算机设备和介质
KR20230158101A (ko) * 2021-03-18 2023-11-17 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 수술 위험도 점수를 생성하는 시스템 및 방법 및 그 용도
KR102559223B1 (ko) * 2021-07-19 2023-07-26 주식회사 디앤피바이오텍 기계 학습에 기반한 조산 위험도 예측 장치
WO2023023475A1 (en) * 2021-08-17 2023-02-23 Birth Model, Inc. Predicting time to vaginal delivery
KR20230150145A (ko) 2022-04-21 2023-10-30 이화여자대학교 산학협력단 마이크로바이옴을 분석하는 학습 모델을 이용한 조산 예측 방법 및 분석장치
CN115227295B (zh) * 2022-09-19 2023-01-24 深圳市雄帝科技股份有限公司 咽拭子采样设备

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US7627437B2 (en) * 2005-01-14 2009-12-01 Idaho Research Foundation Categorization of microbial communities
WO2008073491A1 (en) * 2006-12-11 2008-06-19 University Of Florida Research Foundation, Inc. System and method for analyzing progress of labor and preterm labor
US20110144076A1 (en) * 2008-05-01 2011-06-16 Michelle A Williams Preterm delivery diagnostic assay
US20120270747A1 (en) * 2009-10-29 2012-10-25 The Trustees Of The University Of Pennsylvania Method of predicting risk of pre-term birth
US20110152840A1 (en) * 2009-12-23 2011-06-23 Drugtech Corporation Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
WO2014152985A1 (en) * 2013-03-14 2014-09-25 Children's Hospital Medical Center Biomarkers of preterm necrotizing enterocolitis
US20140287948A1 (en) 2013-03-15 2014-09-25 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
GB2535034A (en) * 2013-07-21 2016-08-10 Whole Biome Inc Methods and systems for microbiome characterization, monitoring and treatment
EP3125905A4 (en) * 2014-04-04 2017-11-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
US10683557B2 (en) * 2014-06-30 2020-06-16 The Chinese University Of Hong Kong Detecting bacterial taxa for predicting adverse pregnancy outcomes

Also Published As

Publication number Publication date
US20190046105A1 (en) 2019-02-14
JP2019511922A (ja) 2019-05-09
US11062808B2 (en) 2021-07-13
EP3416653A4 (en) 2019-06-19
AU2017220785A1 (en) 2018-09-27
CN108778287A (zh) 2018-11-09
EP3416653A1 (en) 2018-12-26
CN108778287B (zh) 2021-08-31
AU2017220785B2 (en) 2019-02-21
JP7060518B2 (ja) 2022-04-26
EP3416653B1 (en) 2022-05-25
WO2017141169A1 (en) 2017-08-24

Similar Documents

Publication Publication Date Title
AR107737A1 (es) Método y sistema para la evaluación temprana de riesgo de resultado de parto prematuro
Penttilä et al. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis
Kepten et al. Improved estimation of anomalous diffusion exponents in single-particle tracking experiments
MX2017008421A (es) Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga.
MX2016013255A (es) Metodos y composiciones para detectar proteinas mal plegadas.
NZ720626A (en) Triaging of patients having asymptomatic hematuria using genotypic and phenotypic biomarkers
PE20171093A1 (es) Composiciones, dispositivos, y metodos de pruebas de sensibilidad del ibs
PE20170298A1 (es) Composiciones y metodos relacionados con el diagnostico del cancer de prostata
MY196578A (en) Method for Determining Stage of Periodontal Disease
BR112019016182A2 (pt) método e uso de um kit para diagnosticar risco de revisão relacionado a implante, e, composição para uso no tratamento de um sujeito que foi diagnosticado com risco de revisão relacionado a implante.
Campá et al. Advanced prostate cancer survival in Spain according to the Gleason score, age and stage
MX2019007040A (es) Composiciones, dispositivos, y métodos de prueba de sensibilidad para el trastorno de déficit de atención/trastorno de hiperactividad con déficit de atención (add/adhd).
Plesa et al. Stemness Signature in AML: GEP with 17 Genes Score Versus Leukemic Stem Cell (LSC) Quantification By Multiparameter Flow Cytometry (MFC)
Traebert et al. Oral cancer in Brazil: dentists' lack of technical knowledge
Widnall et al. An evaluation of retrospective outcome scores in elective foot and ankle surgery
Peirce et al. Diagnostic reliability of sterile speculum exam for rupture of membranes
MX2017004816A (es) Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa.
GB2553736A (en) Method for identification of a deficient BRCA1 function
Girul Poverty in the Dolnośląskie Voivodship
MX2017015031A (es) Metodo para indice de biocomparabilidad.
Fell et al. Uncertainty of Statistical Heterogeneity in Meta-analyses
Kobayashi et al. B51 TUBERCULOSIS: DIAGNOSIS: Study Of Sputum Smear Tuberculosis Positivity In Mucous Sputum (m1 By Miller And Jones Sputum Classifications)
Baghestani et al. Evaluation of parametric models with estimating the prediction error by apparent loss method in analyzing survival of colorectal patients
Ismail A comparison of the long-term consequences of vaginal delivery versus caesarean section on the prevalence, severity and bothersomeness of urinary incontinence subtypes.
Vale et al. Main Determinants of the Extent of Lymphadenectomy in Radical Cystectomy: A Study Based on Clinical Practice